Correlation Between Silo Pharma and Protagenic Therapeutics

Can any of the company-specific risk be diversified away by investing in both Silo Pharma and Protagenic Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Silo Pharma and Protagenic Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Silo Pharma and Protagenic Therapeutics, you can compare the effects of market volatilities on Silo Pharma and Protagenic Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Silo Pharma with a short position of Protagenic Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Silo Pharma and Protagenic Therapeutics.

Diversification Opportunities for Silo Pharma and Protagenic Therapeutics

0.21

Correlation Coefficient

Silo Pharma  Protagenic Therapeutics

Modest diversification

The 3 months correlation between Silo and Protagenic is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Silo Pharma and Protagenic Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Protagenic Therapeutics and Silo Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Silo Pharma are associated (or correlated) with Protagenic Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Protagenic Therapeutics has no effect on the direction of Silo Pharma i.e., Silo Pharma and Protagenic Therapeutics go up and down completely randomly.

Pair Corralation between Silo Pharma and Protagenic Therapeutics

Given the investment horizon of 90 days Silo Pharma is expected to under-perform the Protagenic Therapeutics. But the otc stock apears to be less risky and, when comparing its historical volatility, Silo Pharma is 53.25 times less risky than Protagenic Therapeutics. The otc stock trades about -0.07 of its potential returns per unit of risk. The Protagenic Therapeutics is currently generating about 0.23 of returns per unit of risk over similar time horizon. If you would invest  1.06  in Protagenic Therapeutics on August 30, 2024 and sell it today you would earn a total of  0.38  from holding Protagenic Therapeutics or generate 35.85% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	25.4%
Values	Daily Returns

Silo Pharma  vs.  Protagenic Therapeutics

Silo Pharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Silo Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's essential indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Protagenic Therapeutics

Risk-Adjusted Performance

0 of 100

Solid

Over the last 90 days Protagenic Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly weak basic indicators, Protagenic Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Silo Pharma and Protagenic Therapeutics

The main advantage of trading using opposite Silo Pharma and Protagenic Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Silo Pharma position performs unexpectedly, Protagenic Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Protagenic Therapeutics will offset losses from the drop in Protagenic Therapeutics' long position.

The idea behind Silo Pharma and Protagenic Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.